India's Pharma sector Receives Relief from Trump's Reciprocal Tariff

U.S. President Donald Trump implemented new reciprocal tariffs but excluded pharmaceuticals, energy, and specific minerals to provide relief to India’s generic drug industry. The White House's factsheet stated...

Health Ministry urges states to ensure regular reporting of organ transplant data

The Health Ministry has requested the states that expressed "serious concern" about hospitals not sharing data on organ transplantations and registering them in the National Transplant Registry to submit short status reports every month.In its letter

India Plans to Train Foreign Nations on best Drug regulatory practices

According to the directors, India may soon begin training foreign drug regulators on drug regulatory practices and pharmacovigilance. The initiative may involve regulators and inspectors from African, Southeast Asian, and SAARC nations under the...

Akums Paving the Way for a Greener Future with Rooftop Solar Power Plant

Haridwar, Uttarakhand – Akums, India's pioneering CDMO and one of the early starters in the business of pharma manufacturing, is making a large stride towards a greener and more sustainable tomorrow. Akums has successfully installed a 600 kWp on-grid

Big Pharma Under Scrutiny as India Reports 307 Drug Pricing Violations

A recent report by the Parliamentary Standing Committee on Chemicals and Fertilizers claimed that pharmaceutical companies repeatedly flout drug pricing...

Terbinafine Hydrochloride Prices Set to Rise Amid Supply and Trade Woes

The pharmaceutical industry prepares for worldwide Terbinafine Hydrochloride price increases because of escalating market demand and distribution limitations together with global political challenges. Manufacturers intend to alter their pricing strat

Biocon Pharma Secures USFDA Nod for Norepinephrine and Vital Therapies

The US has approved Biocon Pharma, a subsidiary of Biocon, for its Norepinephrine Bitartrate Injection. Adults with acute hypotension can be treated with the 4 mg/4 mL (1 mg/mL) Norepinephrine Bitartrate Injection in a Single-Dose Vial...

Smaller Pharma Drives Innovation Amid 15% Drop in FDA Drug Approvals

The number of FDA-approved innovator and biosimilar drugs has decreased by 15.44%, from 149 in 2023 to 126 in 2024. According to data and analytics firm GlobalData, the pharmaceutical innovation scene is still thriving despite this slump....

Manufacturers urge the government to reconsider tariffs on medical devices

Local medical device makers based in India are now jolting the state with a plea to reconsider the tax composition of medical devices especially in the segment of...

India Can make wonders in IT and Pharma says Pharma Export Council Rep

The Moscow delegations participated in the II Smart Cities Forum: Russian-Indian Interregional Cooperation to highlight key initiatives aimed at creating a comfortable urban environment, as well as opportunities for international partners.

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.